Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis

Journal of Cell Biology

Volumn 160, Issue 2, 2003, Pages 267-277

  Wolf, Katarina ^a   Mazo, Irina ^b   Leung, Harry ^c   Engelke, Katharina ^c   Von Andrian, Ulrich H ^c   Deryugina, Elena I ^d   Strongin, Alex Y ^d   Bröcker, Eva B ^a   Friedl, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

Carcinoma cells; Cell migration; Fibrosarcoma cells; Invasion; Matrix proteases

Indexed keywords

BETA1 INTEGRIN; CATHEPSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; PROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE;

ARTICLE; CELL INVASION; CELL MIGRATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ACTINS; AMOEBA; ANIMALS; ANTIGENS, CD29; CELL MOVEMENT; CELL SIZE; COLLAGEN; DERMIS; ENDOPEPTIDASES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MESODERM; METALLOENDOPEPTIDASES; MICE; NEOPLASM METASTASIS; NEOPLASMS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; TISSUE TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0037455576     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200209006     Document Type: Article

References (57)

1. Aimes, R.T., and J.P. Quigley. 1995. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem. 270:5872-5876.
2. Bachmeier, B.E., A.G. Nerlich, R. Lichtinghagen, and C.P. Sommerhoff. 2001. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res. 21:3821-3828.
3. Bedi, G.S., and T. Williams. 1994. Purification and characterization of a collagen-degrading protease from Porphyromonas gingivalis. J. Biol. Chem. 269:599-606.
4. Belkin, A.M., S.S. Akimov, L.S. Zaritskaya, B.I. Ratnikov, E.I. Deryugina, and A.Y. Strongin. 2001. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 276:18415-18422.
5. Birchmeier, W., and C. Birchmeier. 1995. Epithelial-mesenchymal transitions in development and tumor progression. EXS. 74:1-15.
6. Birkedal-Hansen, H. 1995. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7:728-735.
7. Brakebusch, C., S. Fillatreau, A.J. Potocnik, G. Bungartz, P. Wilhelm, M. Svensson, P. Kearney, H. Korner, D. Gray, and R. Fassler. 2002. β1 integrin is not essential for hematopoiesis but is necessary for the T cell-dependent IgM antibody response. Immunity. 16:465-477.
8. Brooks, P.C., S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, and D.A. Cheresh, 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell. 85:683-693.
9. Callas, D., P. Bacher, O. Iqbal, D. Hoppensteadt, and J. Fareed. 1994. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin. Thromb. Res. 74:193-205.
10. Coussens, L.M., B. Fingleton, and L.M. Matrisian. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 295:2387-2392.
11. Della, P.P., R. Soeltl, H.W. Krell, K. Collins, M. O'Donoghue, M. Schmitt, and A. Kruger. 1999. Combined treatment with setine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo. Anticancer Res. 19:3809-3816.
12. Deryugina, E.I., G.X. Luo, R.A. Reisfeld, M.A. Bourdon, and A. Strongin. 1997. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res. 17:3201-3210.
13. Deryugina, E.I., M.A. Bourdon, R.A. Reisfeld, and A. Strongin. 1998. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 58:3743-3750.
14. Devreotes, P.N., and S.H. Zigmond. 1988. Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu. Rev. Cell Biol. 4:649-686.
15. Doane, K.J., and D.E. Birk. 1991. Fibroblasts retain their tissue phenotype when grown in three-dimensional collagen gels. Exp. Cell Res. 195:432-442.
16. d'Ortho, M.P., H. Stanton, M. Butler, S.J. Atkinson, G. Murphy, and R.M. Hembry. 1998. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett. 421:159-164.
17. Dufour, S., J.L. Duband, M.J. Humphries, M. Obara, K.M. Yamada, and J.P. Thiery. 1988. Attachment, spreading and locomotion of avian neural crest cells are mediated by multiple adhesion sites on fibronectin molecules. EMBO J. 7:2661-2671.
18. Friedl, P., and E.-B. Bröcker. 2000. The biology of cell locomotion within three-dimensional extracellular matrix. Cell. Mol. Life Sci. 57:41-64.
19. Friedl, P., K. Maaser, C.E. Klein, B. Niggemann, G. Krohne, and K.S. Zanker. 1997. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of α2 and β1 integrins and CD44. Cancer Res. 57:2061-2070.
20. Friedl, P., F. Entschladen, C. Conrad, B. Niggemann, and K.S. Zanker. 1998. CD4+ T lymphocytes migrating in three-dimensional collagen lattices lack focal adhesions and utilize β1 integrin-independent strategies for polarization, interaction with collagen fibers and locomotion. Eur. J. Immunol. 28:2331-2343.
21. Friedl, P., S. Borgmann, and E.B. Bröcker. 2001. Leukocyte crawling through extracellular matrix and the Dictyostelium paradigm of movement: lessons from a social ameba. J. Leukoc. Biol. 70:491-509.
22. Gunzer, M., A. Schäfer, S. Borgmann, S. Grabbe, K.S. Zänker, E.-B. Bröcker, E. Kämpgen, and P. Friedl. 2000. Antigen presentation in three-dimensional extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity. 13:323-332.
23. Hiraoka, N., E. Allen, I.J. Apel, M.R. Gyetko, and S.J. Weiss. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:365-377.
24. Hofmann, U.B., J.R. Westphal, E.T. Waas, A.J. Zendman, I.M. Cornelissen, D.J. Ruiter, and G.N. van Muijen. 1999. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br. J. Cancer. 81:774-782.
25. Ishibashi, O., Y. Mori, T. Kurokawa, and M. Kumegawa. 1999. Breast cancer cells express cathepsins B and L but not cathepsins K or H. Cancer Biochem. Biophys. 17:69-78.
26. Killich, T., P.J. Plath, X. Wei, H. Bultmann, L. Rensing, and M.G. Vicker. 1993. The locomotion, shape and pseudopodial dynamics of unstimulared Dictyostelium cells are not random, J. Cell Sci. 106:1005-1013.
27. Konttinen, Y.T., M. Ainola, H. Valleala, J. Ma, H. Ida, J. Mandelin, R.W. Kinne, S. Santavirta, T. Sorsa, C. Lopez-Otin, and M. Takagi. 1999. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 58:691-697.
28. Kruger, A., R. Soeltl, I. Sopov, C. Kopitz, M. Arlt, V. Magdolen, N. Harbeck, B. Gansbacher, and M. Schmitt. 2001. Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res. 61:1272-1275.
29. Kurschat, P., P. Zigrino, R. Nischt, K. Breitkopf, P. Steurer, C.E. Klein, T. Krieg, and C. Mauch. 1999. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J. Biol. Chem. 274:21056-21062.
30. Langholz, O., D. Rockel, C. Mauch, E. Kozlowska, I. Bank, T. Krieg, and B. Eckes. 1995. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by α1β1 and α1β1 integrins. J. Cell Biol. 131:1903-1915.
31. Lauffenburger, D.A., and A.F. Horwitz. 1996. Cell migration: a physically integrated molecular process. Cell. 84:359-369.
32. Laurent, V., and M. Salzet. 1995. Isolation ofa renin-like enzyme from the leech Theromyzon tessulatum. Peptides. 16:1351-1358.
33. Lewis, W.H. 1934. On the locomotion of the polymorphonuclear neutrophiles of the rat in autoplasma cultures. Bull. Johns Hopkins Hosp. 4:273-279.
34. Lochter, A., S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M.J. Bissell. 1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139:1861-1872.
35. Maaser, K., K. Wolf, C.E. Klein, B. Niggemann, K.S. Zanker, E.B. Brocker, and P. Friedl. 1999. Functional hierarchy of simultaneously expressed adhesion receptors: integrin α1β1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices. Mol. Biol. Cell, 10:3067-3079.
36. Maiti, S., J.B. Shear, R.M. Williams, W.R. Zipfel, and W.W. Webb. 1997. Measuring serotonin distribution in live cells with three-photon excitation. Science. 275:530-532.
37. Mazo, I.B., J.C. Gutierrez-Ramos, P.S. Frenette, R.O. Hynes, D.D. Wagner, and U.H. von Andrian, 1998. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J. Exp. Med. 188:465-474.
38. McCulloch, D.R., M. Harvey, and A.C. Herington. 2000. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol. Cell. Endocrinol. 167:11-21.
39. Mignatti, P., E. Robbins, and D.B. Rifkin. 1986. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell. 47:487-498.
40. Montcourrier, P., P.H. Mangeat, G. Salazar, M. Morisset, A. Sahuquet, and H. Rochefort. 1990. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res. 50:6045-6054.
41. Murphy, G., and J. Gavrilovic. 1999. Proteolysis and cell migration: creating a path? Curr. Opin. Cell Biol. 11:614-621.
42. Nakahara, H., L. Howard, E.W. Thompson, H. Sato, M. Seiki, Y. Yeh, and W.T. Chen. 1997. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA. 94:7959-7964.
43. Nisbet, A.J., and P.F. Billingsley. 1999. Hydrolytic enzymes of Psoroptes cuniculi (Delafond). Insect Biochem. Mol. Biol. 29:25-32.
44. Nobes, C.D., and A. Hall. 1999. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144:1235-1244.
45. Ntayi, C., S. Lorimier, O. Berthier-Vergnes, W. Hornebeck, and P. Bernard. 2001. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices. Exp. Cell Res. 270:110-118.
46. Ohuchi, E., K. Imai, Y. Fujii, H. Sato, M. Seiki, and Y. Okada. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:2446-2451.
47. Palecek, S.P., J.C. Loftus, M.H. Ginsberg, D.A. Lauffenburger, and A.F. Horwitz. 1997. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature. 385:537-540.
48. Redfield, A., M.T. Nieman, and K.A. Knudsen. 1997. Cadherins promote skeletal muscle differentiation in three-dimensional cultures. J. Cell Biol. 138:1323-1331.
49. Sassi, M.L., H. Eriksen, L. Risteli, S. Niemi, J. Mansell, M. Gowen, and J. Risteli. 2000. Immunochemical characterization of assay for carboxy-terminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone. 26:367-373.
50. Schor, S.L., T.D. Allen, and B. Winn. 1983. Lymphocyte migration into three-dimensional collagen matrices: a quantitative study. J. Cell Biol. 96:1089-1096.
51. Sheetz, M.P., D.P. Felsenfeld, and C.G. Galbraith. 1998. Cell migration: regulation of force on extracellular-matrix-integrin complexes. Trends Cell Biol. 8:51-54.
52. Sternlicht, M.D., and Z. Werb. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516.
53. Stetler-Stevenson, W.G., S. Aznavoorian, and L.A. Liotta. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:541-573.
54. Wei, Y., M. Lukashev, D.I. Simon, S.C. Bodary, S. Rosenberg, M.V. Doyle, and H.A. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science. 273:1551-1555.
55. Welch, M.P., G.F. Odland, and R.A. Clark. 1990. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J. Cell Biol. 110:133-145.
56. Yumura, S., H. Mori, and Y. Fukui. 1984. Localization ofactin and myosin for the study of ameboid movement in Dicryostelium using improved immunofluorescence. J. Cell Biol. 99:894-899.
57. Zucker, S., J. Cao, and W.T. Chen. 2000. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene. 19:6642-6650.